Current status of treatment for colorectal liver metastases in the United Kingdom

作     者：Kentaro Okamoto Hiroyuki Uetake 

作者机构：Graduate SchoolTokyo Medical and Dental UniversityTokyoJapan 

出 版 物：《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养（英文）)

年 卷 期：2021年第10卷第1期

页      面：116-118页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：liver treatment chemotherapy curative 

摘      要：Hepatectomy is the treatment choice for resectable colorectal cancer(CRC)liver metastases(LM)(CRCLM)according to the national guidelines(1-3).The National Comprehensive Cancer Network guidelines indicate that the treatment for liver-limited metastases depends on the resectability(1).In the European Society for Medical Oncology guideline,a similar statement is made on the treatment of resectable CRCLM,except for the recommendation of perioperative chemotherapy for some populations with resectable CRCLM(2).In the Japanese Society for Cancer of the Colon and Rectum(JSCCR)guidelines,hepatic resection is recommended for LMs if all the lesions are curatively resectable(3).